가이드와이어 시장 규모, 점유율, 동향 분석 보고서 : 제품별, 지역별, 부문별 예측(2026-2033년)

Guidewires Market Summary

The global guidewires market size was valued at USD 2.88 billion in 2025 and is projected to reach USD 4.43 billion by 2033, growing at a CAGR of 5.53% from 2026 to 2033. The growth of the guidewires market is driven by the rising volume of minimally invasive and catheter-based procedures, increasing prevalence of cardiovascular and peripheral vascular diseases, continuous advancements in guidewire design and materials to improve flexibility and torque control, and expanding adoption of interventional procedures across hospitals and ambulatory surgical centers worldwide.

The rising global burden of cardiovascular diseases, including coronary artery disease, peripheral artery disease, and structural heart disorders, is one of the significant growth drivers for the guidewires market. As the incidence of CVD increases due to ageing populations, sedentary lifestyles, obesity, diabetes, and hypertension, hospitals are witnessing a higher volume of diagnostic and interventional procedures such as angioplasty, stent placement, catheter-based imaging, and minimally invasive vascular repairs. These procedures rely heavily on guidewires for navigating complex vasculature, crossing occlusions, and enabling precise device placement. Moreover, the growing preference for minimally invasive interventions, favored for shorter hospital stays, reduced complications, and better patient outcomes, further accelerates the demand for highly specialized guidewires.

Moreover, angina pectoris, a leading cause of morbidity and mortality globally, affects a significant number of individuals. For instance, according to the National Library of Medicine, the prevalence of angina pectoris worldwide ranged from approximately 2.0% to 7.0% in 2024. In addition, in 2023, there were over 2,806,000 reported cases of angina pectoris in China. There is evidence that angina doubles the risk of serious cardiovascular events. Currently, coronary artery disease (CAD) accounts for 4.1 million deaths in Europe annually, with individuals over 65 accounting for 82.0% of these deaths.

Technological advancements are one of the key factors boosting the application of the guidewire. The advanced guidewires can be customized for specific requirements and can be operated remotely. This leads to an increased success rate of the procedures and thus the adoption rate for minimally invasive surgeries. The integration of these guidewires with imaging modalities and surgical robots has endless applications in modern surgical practices. For instance, in April 2024, Teleflex Incorporated introduced the Wattson Temporary Pacing Guidewire, designed specifically for use during Balloon Aortic Valvuloplasty (BAV) and Transcatheter Aortic Valve Replacement (TAVR). This guidewire offers supporting valve delivery, dual functionality, and ventricular bipolar pacing. It aims to improve procedural efficiencies and reduce complications associated with traditional methods.

Furthermore, rising geriatric population further fuels market growth. For instance, the WHO estimates that by 2030, 1 in 6 people worldwide will be 60 years of age or older. The same demographic will double by 2050. Moreover, diseases are far more common among older adults. These include cardiovascular disease, ischemic heart disease, vascular dementia, and multiple sclerosis, among others.

Global Guidewires Market Report Segmentation

This report forecasts revenue growth at country levels and provides an analysis on the latest industry trends and opportunities in each of the sub-segments from 2021 to 2033. For the purpose of this study, Grand View Research has segmented the guidewires market report on the basis of product, and region:

• Product Outlook (Revenue, USD Million, 2021 - 2033)
• Coronary Guidewires
• Peripheral Guidewires
• Urology Guidewires
• Neurovascular Guidewires
• Region Outlook (Revenue, USD Million, 2021 - 2033)
• North America
  • U.S.
  • Canada
  • Mexico
• Europe
  • UK
  • Germany
  • France
  • Italy
  • Spain
  • Denmark
  • Sweden
  • Norway
• Asia Pacific
  • Japan
  • China
  • India
  • Australia
  • South Korea
  • Thailand
• Latin America
  • Brazil
  • Argentina
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE
  • Kuwait

Table of Contents

Chapter 1. Methodology and Scope

• 1.1. Market Segmentation and Scope
• 1.2. Segment Definitions
  • 1.2.1. Product
  • 1.2.2. Regional scope
  • 1.2.3. Estimates and forecasts timeline
• 1.3. Research Methodology
• 1.4. Information Procurement
  • 1.4.1. Purchased database
  • 1.4.2. GVR's internal database
  • 1.4.3. Secondary sources
  • 1.4.4. Primary research
  • 1.4.5. Details of primary research
• 1.5. Information or Data Analysis
  • 1.5.1. Data analysis models
• 1.6. Market Formulation & Validation
• 1.7. Model Details
  • 1.7.1. Commodity flow analysis (Model 1)
  • 1.7.2. Approach 1: Commodity flow approach
  • 1.7.3. Volume price analysis (Model 2)
  • 1.7.4. Approach 2: Volume price analysis
• 1.8. List of Secondary Sources
• 1.9. List of Primary Sources
• 1.10. Objectives

Chapter 2. Executive Summary

• 2.1. Market Outlook
• 2.2. Segment Outlook
• 2.3. Regional outlook
• 2.4. Competitive Insights

Chapter 3. Guidewires Market Variables, Trends & Scope

• 3.1. Market Lineage Outlook
  • 3.1.1. Parent Market Outlook
  • 3.1.2. Related/ancillary market outlook
• 3.2. Market Dynamics
  • 3.2.1. Market Driver Analysis
    • 3.2.1.1. Rising burden of cardiovascular & peripheral diseases
    • 3.2.1.2. Growing adoption of minimally invasive procedures
    • 3.2.1.3. Technological advancements in guidewire design
    • 3.2.1.4. Expansion of Cath labs and interventional centers
    • 3.2.1.5. Increasing stroke intervention adoption
    • 3.2.1.6. Strong industry presence & distribution networks
  • 3.2.2. Market Restraint Analysis
    • 3.2.2.1. Alternative treatment options
    • 3.2.2.2. Stringent regulatory requirements
    • 3.2.2.3. Potential risks and complications
  • 3.2.3. Market Opportunity Analysis
    • 3.2.3.1. High growth in emerging markets
    • 3.2.3.2. Adoption of robot-assisted & imaging-guided interventions
    • 3.2.3.3. Increased use of premium CTO & specialty wires
    • 3.2.3.4. Product differentiation through materials & coatings
    • 3.2.3.5. Local manufacturing & OEM opportunities
    • 3.2.3.6. Rising Focus on Neurovascular Interventions
  • 3.2.4. Market Challenge Analysis
    • 3.2.4.1. Supply chain constraints (nitinol & specialty coatings)
    • 3.2.4.2. Growing competition & market saturation
• 3.3. Guidewires Market Analysis Tools
  • 3.3.1. Industry Analysis - Porter's
    • 3.3.1.1. Bargaining power of suppliers
    • 3.3.1.2. Bargaining power of buyers
    • 3.3.1.3. Threat of substitutes
    • 3.3.1.4. Threat of new entrants
    • 3.3.1.5. Competitive rivalry
  • 3.3.2. PESTEL Analysis
    • 3.3.2.1. Political landscape
    • 3.3.2.2. Economic landscape
    • 3.3.2.3. Social landscape
    • 3.3.2.4. Technological landscape
    • 3.3.2.5. Environmental landscape
    • 3.3.2.6. Legal landscape

Chapter 4. Guidewires Market: Product Estimates & Trend Analysis

• 4.1. Segment Dashboard
• 4.2. Guidewires Market: Product Movement Analysis
• 4.3. Guidewires Market by Product Outlook (USD Million)
• 4.4. Market Size & Forecasts and Trend Analyses, 2021 to 2033 for the following
• 4.5. Coronary Guidewires
  • 4.5.1. Coronary Guidewires Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
• 4.6. Peripheral Guidewires
  • 4.6.1. Peripheral Guidewires Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
• 4.7. Urology Guidewires
  • 4.7.1. Urology Guidewires Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
• 4.8. Neurovascular Guidewires
  • 4.8.1. Neurovascular Guidewires Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 5. Guidewires Market: Regional Estimates & Trend Analysis

• 5.1. Regional Dashboard
• 5.2. Regional Guidewires Market movement analysis
• 5.3. Guidewires Market: Regional Estimates & Trend Analysis by Diagnosis
• 5.4. Market Size & Forecasts and Trend Analyses, 2021 to 2033 for the following
• 5.5. North America
  • 5.5.1. North America Guidewires Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 5.5.2. U.S.
    • 5.5.2.1. Key Country Dynamics
    • 5.5.2.2. Competitive Scenario
    • 5.5.2.3. Regulatory Framework
    • 5.5.2.4. Reimbursement scenario
    • 5.5.2.5. U.S. Guidewires Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 5.5.3. Canada
    • 5.5.3.1. Key Country Dynamics
    • 5.5.3.2. Competitive Scenario
    • 5.5.3.3. Regulatory Framework
    • 5.5.3.4. Reimbursement scenario
    • 5.5.3.5. Canada Guidewires Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 5.5.4. Mexico
    • 5.5.4.1. Key Country Dynamics
    • 5.5.4.2. Competitive Scenario
    • 5.5.4.3. Regulatory Framework
    • 5.5.4.4. Reimbursement scenario
    • 5.5.4.5. Mexico Guidewires Market Estimates and Forecasts, 2021 - 2033 (USD Million)
• 5.6. Europe
  • 5.6.1. Europe Guidewires Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 5.6.2. UK
    • 5.6.2.1. Key Country Dynamics
    • 5.6.2.2. Competitive Scenario
    • 5.6.2.3. Regulatory Framework
    • 5.6.2.4. Reimbursement scenario
    • 5.6.2.5. UK Guidewires Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 5.6.3. Germany
    • 5.6.3.1. Key Country Dynamics
    • 5.6.3.2. Competitive Scenario
    • 5.6.3.3. Regulatory Framework
    • 5.6.3.4. Reimbursement scenario
    • 5.6.3.5. Germany Guidewires Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 5.6.4. France
    • 5.6.4.1. Key Country Dynamics
    • 5.6.4.2. Competitive Scenario
    • 5.6.4.3. Regulatory Framework
    • 5.6.4.4. Reimbursement scenario
    • 5.6.4.5. France Guidewires Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 5.6.5. Italy
    • 5.6.5.1. Key Country Dynamics
    • 5.6.5.2. Competitive Scenario
    • 5.6.5.3. Regulatory Framework
    • 5.6.5.4. Reimbursement scenario
    • 5.6.5.5. Italy Guidewires Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 5.6.6. Spain
    • 5.6.6.1. Key Country Dynamics
    • 5.6.6.2. Competitive Scenario
    • 5.6.6.3. Regulatory Framework
    • 5.6.6.4. Reimbursement scenario
    • 5.6.6.5. Spain Guidewires Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 5.6.7. Denmark
    • 5.6.7.1. Key Country Dynamics
    • 5.6.7.2. Competitive Scenario
    • 5.6.7.3. Regulatory Framework
    • 5.6.7.4. Reimbursement scenario
    • 5.6.7.5. Denmark Guidewires Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 5.6.8. Sweden
    • 5.6.8.1. Key Country Dynamics
    • 5.6.8.2. Competitive Scenario
    • 5.6.8.3. Regulatory Framework
    • 5.6.8.4. Reimbursement scenario
    • 5.6.8.5. Sweden Guidewires Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 5.6.9. Norway
    • 5.6.9.1. Key Country Dynamics
    • 5.6.9.2. Competitive Scenario
    • 5.6.9.3. Regulatory Framework
    • 5.6.9.4. Reimbursement scenario
    • 5.6.9.5. Norway Guidewires Market Estimates and Forecasts, 2021 - 2033 (USD Million)
• 5.7. Asia Pacific
  • 5.7.1. Asia Pacific Guidewires Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 5.7.2. Japan
    • 5.7.2.1. Key Country Dynamics
    • 5.7.2.2. Competitive Scenario
    • 5.7.2.3. Regulatory Framework
    • 5.7.2.4. Reimbursement scenario
    • 5.7.2.5. Japan Guidewires Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 5.7.3. China
    • 5.7.3.1. Key Country Dynamics
    • 5.7.3.2. Competitive Scenario
    • 5.7.3.3. Regulatory Framework
    • 5.7.3.4. Reimbursement scenario
    • 5.7.3.5. China Guidewires Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 5.7.4. India
    • 5.7.4.1. Key Country Dynamics
    • 5.7.4.2. Competitive Scenario
    • 5.7.4.3. Regulatory Framework
    • 5.7.4.4. Reimbursement scenario
    • 5.7.4.5. India Guidewires Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 5.7.5. South Korea
    • 5.7.5.1. Key Country Dynamics
    • 5.7.5.2. Competitive Scenario
    • 5.7.5.3. Regulatory Framework
    • 5.7.5.4. Reimbursement scenario
    • 5.7.5.5. South Korea Guidewires Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 5.7.6. Australia
    • 5.7.6.1. Key Country Dynamics
    • 5.7.6.2. Competitive Scenario
    • 5.7.6.3. Regulatory Framework
    • 5.7.6.4. Reimbursement scenario
    • 5.7.6.5. Australia Guidewires Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 5.7.7. Thailand
    • 5.7.7.1. Key Country Dynamics
    • 5.7.7.2. Competitive Scenario
    • 5.7.7.3. Regulatory Framework
    • 5.7.7.4. Reimbursement scenario
    • 5.7.7.5. Thailand Guidewires Market Estimates and Forecasts, 2021 - 2033 (USD Million)
• 5.8. Latin America
  • 5.8.1. Latin America Guidewires Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 5.8.2. Brazil
    • 5.8.2.1. Key Country Dynamics
    • 5.8.2.2. Competitive Scenario
    • 5.8.2.3. Regulatory Framework
    • 5.8.2.4. Reimbursement scenario
    • 5.8.2.5. Brazil Guidewires Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 5.8.3. Argentina
    • 5.8.3.1. Key Country Dynamics
    • 5.8.3.2. Competitive Scenario
    • 5.8.3.3. Regulatory Framework
    • 5.8.3.4. Reimbursement scenario
    • 5.8.3.5. Argentina Guidewires Market Estimates and Forecasts, 2021 - 2033 (USD Million)
• 5.9. Middle East & Africa
  • 5.9.1. Middle East & Africa Guidewires Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 5.9.2. South Africa
    • 5.9.2.1. Key Country Dynamics
    • 5.9.2.2. Competitive Scenario
    • 5.9.2.3. Regulatory Framework
    • 5.9.2.4. Reimbursement scenario
    • 5.9.2.5. South Africa Guidewires Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 5.9.3. Saudi Arabia
    • 5.9.3.1. Key Country Dynamics
    • 5.9.3.2. Competitive Scenario
    • 5.9.3.3. Regulatory Framework
    • 5.9.3.4. Reimbursement scenario
    • 5.9.3.5. Saudi Arabia Guidewires Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 5.9.4. UAE
    • 5.9.4.1. Key Country Dynamics
    • 5.9.4.2. Competitive Scenario
    • 5.9.4.3. Regulatory Framework
    • 5.9.4.4. Reimbursement scenario
    • 5.9.4.5. UAE Guidewires Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 5.9.5. Kuwait
    • 5.9.5.1. Key Country Dynamics
    • 5.9.5.2. Competitive Scenario
    • 5.9.5.3. Regulatory Framework
    • 5.9.5.4. Reimbursement scenario
    • 5.9.5.5. Kuwait Guidewires Market Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 6. Competitive Landscape

• 6.1. Market Participant Categorization
• 6.2. Company Share Analysis, 2025
• 6.3. Key Company Profiles
  • 6.3.1. Boston Scientific Corporation
    • 6.3.1.1. Company overview
    • 6.3.1.2. Financial performance
    • 6.3.1.3. Product benchmarking
    • 6.3.1.4. Strategic initiatives
  • 6.3.2. Medtronic
    • 6.3.2.1. Company overview
    • 6.3.2.2. Financial performance
    • 6.3.2.3. Product benchmarking
    • 6.3.2.4. Strategic initiatives
  • 6.3.3. Cook
    • 6.3.3.1. Company overview
    • 6.3.3.2. Financial performance
    • 6.3.3.3. Product benchmarking
    • 6.3.3.4. Strategic initiatives
  • 6.3.4. B. Braun
    • 6.3.4.1. Company overview
    • 6.3.4.2. Financial performance
    • 6.3.4.3. Product benchmarking
    • 6.3.4.4. Strategic initiatives
  • 6.3.5. Terumo Medical Corporation
    • 6.3.5.1. Company overview
    • 6.3.5.2. Financial performance
    • 6.3.5.3. Product benchmarking
    • 6.3.5.4. Strategic initiatives
  • 6.3.6. Abbott
    • 6.3.6.1. Company overview
    • 6.3.6.2. Financial performance
    • 6.3.6.3. Product benchmarking
    • 6.3.6.4. Strategic initiatives
  • 6.3.7. Stryker
    • 6.3.7.1. Company overview
    • 6.3.7.2. Financial performance
    • 6.3.7.3. Product benchmarking
    • 6.3.7.4. Strategic initiatives
  • 6.3.8. Teleflex Incorporated
    • 6.3.8.1. Company overview
    • 6.3.8.2. Financial performance
    • 6.3.8.3. Product benchmarking
    • 6.3.8.4. Strategic initiatives
  • 6.3.9. Codman Neuro (Integer Holdings Corporation)
    • 6.3.9.1. Company overview
    • 6.3.9.2. Financial performance
    • 6.3.9.3. Product benchmarking
    • 6.3.9.4. Strategic initiatives
  • 6.3.10. Merit Medical Systems
    • 6.3.10.1. Company overview
    • 6.3.10.2. Financial performance
    • 6.3.10.3. Product benchmarking
    • 6.3.10.4. Strategic initiatives
  • 6.3.11. BD
    • 6.3.11.1. Company overview
    • 6.3.11.2. Financial performance
    • 6.3.11.3. Product benchmarking
    • 6.3.11.4. Strategic initiatives
  • 6.3.12. Olympus Corporation
    • 6.3.12.1. Company overview
    • 6.3.12.2. Financial performance
    • 6.3.12.3. Product benchmarking
    • 6.3.12.4. Strategic initiatives
  • 6.3.13. Asahi Intecc Co., Ltd.
    • 6.3.13.1. Company overview
    • 6.3.13.2. Financial performance
    • 6.3.13.3. Product benchmarking
    • 6.3.13.4. Strategic initiatives
  • 6.3.14. ConMed Corporation
    • 6.3.14.1. Company overview
    • 6.3.14.2. Financial performance
    • 6.3.14.3. Product benchmarking
    • 6.3.14.4. Strategic initiatives
  • 6.3.15. Argon Medical Devices
    • 6.3.15.1. Company overview
    • 6.3.15.2. Financial performance
    • 6.3.15.3. Product benchmarking
    • 6.3.15.4. Strategic initiatives
  • 6.3.16. SP Medical A/S
    • 6.3.16.1. Company overview
    • 6.3.16.2. Financial performance
    • 6.3.16.3. Product benchmarking
    • 6.3.16.4. Strategic initiatives
  • 6.3.17. TE Connectivity (formerly Creganna Medical)
    • 6.3.17.1. Company overview
    • 6.3.17.2. Financial performance
    • 6.3.17.3. Product benchmarking
    • 6.3.17.4. Strategic initiatives
  • 6.3.18. Galt Medical Corp
    • 6.3.18.1. Company overview
    • 6.3.18.2. Financial performance
    • 6.3.18.3. Product benchmarking
    • 6.3.18.4. Strategic initiatives
  • 6.3.19. Balton
    • 6.3.19.1. Company overview
    • 6.3.19.2. Financial performance
    • 6.3.19.3. Product benchmarking
    • 6.3.19.4. Strategic initiatives
  • 6.3.20. Manish Medi Innovation
    • 6.3.20.1. Company overview
    • 6.3.20.2. Financial performance
    • 6.3.20.3. Product benchmarking
    • 6.3.20.4. Strategic initiatives
  • 6.3.21. ST. Stone Medical Devices Private Limited
    • 6.3.21.1. Company overview
    • 6.3.21.2. Financial performance
    • 6.3.21.3. Product benchmarking
    • 6.3.21.4. Strategic initiatives
  • 6.3.22. Custom Wire Technologies, Inc.
    • 6.3.22.1. Company overview
    • 6.3.22.2. Financial performance
    • 6.3.22.3. Product benchmarking
    • 6.3.22.4. Strategic initiatives
  • 6.3.23. ACE Medical Devices
    • 6.3.23.1. Company overview
    • 6.3.23.2. Financial performance
    • 6.3.23.3. Product benchmarking
    • 6.3.23.4. Strategic initiatives
  • 6.3.24. BrosMed Medical Co., Ltd.
    • 6.3.24.1. Company overview
    • 6.3.24.2. Financial performance
    • 6.3.24.3. Product benchmarking
    • 6.3.24.4. Strategic initiatives
  • 6.3.25. Cathwide Medical Co. Ltd.
    • 6.3.25.1. Company overview
    • 6.3.25.2. Financial performance
    • 6.3.25.3. Product benchmarking
    • 6.3.25.4. Strategic initiatives
  • 6.3.26. Creo Medical
    • 6.3.26.1. Company overview
    • 6.3.26.2. Financial performance
    • 6.3.26.3. Product benchmarking
    • 6.3.26.4. Strategic initiatives
  • 6.3.27. Foshan Dihua Technology Co., Ltd.
    • 6.3.27.1. Company overview
    • 6.3.27.2. Financial performance
    • 6.3.27.3. Product benchmarking
    • 6.3.27.4. Strategic initiatives
  • 6.3.28. AngioDynamics
    • 6.3.28.1. Company overview
    • 6.3.28.2. Financial performance
    • 6.3.28.3. Product benchmarking
    • 6.3.28.4. Strategic initiatives
  • 6.3.29. Cordis (Cardinal Health)
    • 6.3.29.1. Company overview
    • 6.3.29.2. Financial performance
    • 6.3.29.3. Product benchmarking
    • 6.3.29.4. Strategic initiatives